References
- Cao A, Gossens M, Pirastu M. β Thalassaemia mutations in Mediterranean populations. Br J Haematol. 2008;71(3):309–312.
- Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D541.
- Labie D, Bennani C, Beldjord C. β-Thalassemia in Algeria. Ann NY Acad Sci. 1990;612:43–54.
- Bennani C, Bouhass R, Perrin-Pecontal P, et al. Anthropological approach to the heterogeneity of β-thalassemia mutations in northern Africa . Hum Biol. 1994;66(3):369–382.
- Bennani C, Tamouza R, Rouabhi F, et al. The spectrum of β-thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol. 1993;84(2):335–337.
- Boudrahem-Addour N, Zidani N, Carion N, et al. Molecular heterogeneity of β-thalassemia in Algeria: how to face up to a major health problem. Hemoglobin. 2009;33(1):24–36.
- Bouhass R, Perrin P, Trabuchet G. The spectrum of β-thalassemia mutations in the Oran region of Algeria. Hemoglobin. 1994;18(3):211–219.
- Ouali F, Siala H, Bibi A, et al. Prenatal diagnosis of hemoglobinopathies in Tunisia: an 18 years of experience. Int J Lab Hem. 2016;38(3):223–232.
- Thein SL. Genetic basis and genetic modifiers of β-thalassemia and sickle cell disease. Adv Exp Med Biol. 2017;1013:27–57.
- Danjou F, Anni F, Perseu L, et al. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica. 2012;97(7):989–993.
- Danjou F, Francavilla M, Anni F, et al. A genetic score for the prediction of β-thalassemia severity. Haematologica. 2015;100(4):452–457.
- Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of β-thalassemia. Blood. 2000;95(1):360–362.
- Joly P, Lacan P, Garcia C, et al. Rapid and reliable β-globin gene cluster haplotyping of sickle cell disease patients by FRET Light Cycler and HRM assays. Clin Chim Acta. 2011;412(13-14):1257–1261.
- Fattoum S, Messaoud T, Bibi A. Molecular basis of β-thalassemia in the population of Tunisia. Hemoglobin. 2004;28(3):177–187.
- Jouini L, Sahli CA, Laaouini N, et al. Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients. Mol Biol Rep. 2013;40(11):6205–6212.
- Labie D, Benabadji M, Elion J. Genetic disorders in North African populations of the Maghreb: Morocco, Algeria and Tunisia. In: Teebi AS, Farag TI, Editors. Genetic Disorders Among Arab Populations. New York (NY, USA): Oxford University Press. 1995. 290–321.
- Kurtoglu A, Karakus V, Erkal O, et al. β-Thalassemia gene mutations in Antalya, Turkey: results from a single centre study. Hemoglobin. 2017;40(6):392–395.
- Khelil AH, Laradi S, Ferchichi S, et al. [Diagnostic strategy of β-thalassemic mutation in a Tunisian family, application in prenatal diagnosis]. Ann Biol Clin (Paris). 2003;61(2):229–233.
- Omar A, Abdel Karim E, Gendy WE, et al. Molecular basis of β-thalassemia in Alexandria. Egypt J Immunol. 2005;12(1):15–24.
- Perrin P, Bouhassa R, Mselli L, et al. Diversity of sequence haplotypes associated with β-thalassaemia mutations in Algeria: implications for their origin. Gene. 1998;213(1-2):169–177.
- Soliman OE, Yahia S, Shouma A, et al. Reverse hybridization StripAssay detection of β-thalassemia mutations in northeast Egypt. Hematology. 2010;15(3):182–186.
- Gueye Tall F, Martin C, Malick Ndour EH, et al. Genetic background of the sickle cell disease pediatric population of Dakar, Senegal, and characterization of a novel frameshift β-thalassemia mutation [HBB: c.265_266del; p.Leu89Glufs*2]. Hemoglobin. 2017;41(2):89–95.
- Renoux C, Connes P, Nader E, et al. β-Thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changes. Pediatr Blood Cancer. 2017;64(8):e26455.
- Hafiani K, Bazoui H, El Mahdi Y, et al. Major sickle cell syndromes in children in Kenitra, Morocco. Asian Pac J Trop Dis. 2017;7(11):688–690.
- Bener A, Al-Mulla M, Clarke A. Premarital screening and genetic counseling program: studies from an endogamous population. Int J Appl Basic Med Res. 2019;9(1):20–26.
- Forster L, Ardakani RM, Qadah T, et al. The effect of nonsense mediated decay on transcriptional activity within the novel β-thalassemia mutation HBB: c.129delT. Hemoglobin. 2015;39(5):334–339.
- Mesbah-Amroun H, Rouabhi F, Ducrocq R, et al. Molecular basis of β-thalassemia in Algeria. Hemoglobin. 2008;32(3):273–278.
- Said F, Abdel-Salam A. XmnI polymorphism: relation to β-thalassemia phenotype and genotype in Egyptian children. Egypt J Med Hum Genet. 2015;16(2):123–127.
- Yang Z, Cui Q, Zhou W, et al. Comparison of gene mutation spectrum of thalassemia in different regions of China and Southeast Asia. Mol Genet Genomic Med. 2019;7(6):e680.